About
Ibogaine Legal Map is an independent information resource focused on Where Is Ibogaine Legal? Country-by-country. We are newly launched with a clear mission: provide reliable, verifiable information for people seeking a concise, country-level view without promoting clinical services.
Our site tagline — Independent information on Where Is Ibogaine Legal? Country-by-country. — explains scope and tone. If you want to return to the site overview and interactive tools, use the main map and site index at the front page of the project.
For visitors who prefer a concise primer about ibogaine therapy itself we reference authoritative background material; for example, general context about substance-regulation approaches is summarized by sources such as the United States Drug Enforcement Administration's policy pages and academic overviews like the Wikipedia entry on ibogaine.
Our editorial approach
We compile and maintain country-level summaries, aggregated references, and explanatory notes about Where Is Ibogaine Legal? Country-by-country. Our approach prioritizes primary sources (government registries, legislative texts) and reputable institutional summaries; where primary texts are inaccessible we rely on official public records and academic literature and note the provenance.
How information is sourced
Research begins with official government and regulatory pages, then cross-checks with academic publications or established databases. Where appropriate we cite country legislation or ministry guidance directly; when legislation is not available online we record the last-checked date and the registry used. For methodological standards we follow conventions similar to those used by public policy research centers and university-based research groups such as Harvard's public policy resources (harvard.edu).
How content is organized
Content is organized into an interactive country map, a concise country note for each jurisdiction, and a set of explanatory pages that describe how regulation is typically codified. To navigate between summaries and deeper notes, use the top-level map and the dedicated "Country Notes" section; editorially we keep the country pages short and cited so readers can follow original sources.
Editorial principles
- Independence — we do not accept funding that dictates coverage.
- Clarity — citations visible and verifiable; dates of last review recorded.
- Accuracy — prefer primary sources and conservative interpretation.
- Transparency — method notes accompany summaries.
To explore the broader site structure and services tied to our editorial work, see the description of offerings on our services and data-access page, which explains subscription-level API access and institutional licensing in plain terms.
We also keep an accessible summary of methodology and sourcing so civic researchers and journalists can reuse our citations; the home index includes an overview and the interactive map for quick orientation at the project root (the main site page).
Who this is for
Our audience includes researchers, journalists, policy professionals, and curious members of the public who need a country-by-country overview rather than clinical guidance. If you are evaluating treatment options or seeking medical advice, consult licensed professionals — our content is informational only.
For readers looking for concise background on the broader regulatory frameworks that often shape national practice, explanatory resources such as government policy pages and educational institutions can provide complementary context (for example, national regulatory overview pages or university summaries).
We also keep an internal index and recommended primary-source pathways on the site; the front page's map and navigation help users move between country notes and methodological appendices. If you are returning from a partner site or an academic citation, you may find the site's structured country notes efficient for citation and follow-up.
Independent by design
Ibogaine Legal Map is an independent information company, not a clinic or medical provider. Its content is not medical or legal advice. We state this clearly across the site to avoid any confusion about our role as an editorial resource.
Where legal interpretation is required, we point readers to primary legislative texts and official government sources; when those sources are hosted by national administrations we link to them directly in the country notes. For readers who want an explanatory primer about the therapy itself, the What Is Ibogaine Therapy resource offers an introductory perspective and is one of several context sources we consult when preparing summaries.
If you would like to return to the site index and interactive map, there is a prominent entry at the project's root that aggregates country summaries and links back to the editorial methodology described above: visit the site front page for the index and tools.
